The FDA has issued guidance on the upcoming replacement for the US’ Voluntary Cosmetic Registration Program under MoCRA – so what can the industry expect? An expert shares their expectations
MoCRA was signed into law as part of the Food and Drug Omnibus Reform Act of 2022
This week, the country’s Food and Drug Administration (FDA) unveiled the draft guidance for a new programme under MoCRA, the Modernization of Cosmetic Regulations Act of 2022.
The draft confirmed FDA plans for the system to go live in approximately two months’ time.
The much-anticipated launch follows the suspension of the old Voluntary Cosmetic Registration Program (VCRP) earlier this year.
MoCRA was signed into law as part of the Food and Drug Omnibus Reform Act of 2022 (FDORA) on 29 December 2022.
“MoCRA requires that every person that owns or operates a facility that ‘engages in the manufacturing or processing of a cosmetic product for distribution in the United States’ register that facility with FDA, update content within 60 days of any changes, and renew their registration every two years,” explains Kelly Bonner, an associate at Philadelphia law firm Duane Morris LLP.
This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.
Subscribe now to premium content on Cosmetics Business